Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00939393 · ClinicalTrials.gov registry record · NA

Balloon Sinus Dilation In Office or OR

A NA study, sponsored by Integra LifeSciences Corporation.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT00939393 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 72 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00939393, a NA study, has completed, sponsored by Integra LifeSciences Corporation.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

Endoscopic sinus surgery will be performed either in the physician's office or in the operating room (OR). Patients treated in the physician's office will have endoscopic sinus surgery performed with balloon sinuplasty devices. Patients treated in the OR will have endoscopic sinus surgery performed with or without balloon sinuplasty devices.

Interventions

  • DEVICE FESS instruments with or without balloon treatment
  • DEVICE Balloon Sinuplasty

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2008-04-01
Est. Completion 2010-07-01
Phase NA

Sponsor

Integra LifeSciences Corporation

60 total trials

What the Registry Record Tells You About NCT00939393

The ClinicalTrials.gov registry entry for NCT00939393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which FESS instruments with or without balloon treatment is the first listed.

NCT00939393 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00939393 about?

NCT00939393 is a clinical study titled "Balloon Sinus Dilation In Office or OR". Endoscopic sinus surgery will be performed either in the physician's office or in the operating room (OR). Patients treated in the physician's office will have endoscopic sinus surgery performed with balloon sinuplasty devices. Patients treated in the OR will have endoscopic sinus surgery performed ...

What is the current status of trial NCT00939393?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2008-04-01. Estimated completion is 2010-07-01.

What interventions are being tested in trial NCT00939393?

The interventions under investigation include: FESS instruments with or without balloon treatment (DEVICE), Balloon Sinuplasty (DEVICE).

Who is sponsoring clinical trial NCT00939393?

This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.